ReviewAdvances in experimental medicine and biology2020

Therapeutic Efficacy of Plasmalogens for Alzheimer's Disease, Mild Cognitive Impairment, and Parkinson's Disease in Conjunction with a New Hypothesis for the Etiology of Alzheimer's Disease.

Takehiko Fujino et al.PubMed ↗Publisher ↗

No numbers read from the abstract.